Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. (Q48714160)

14 February 2018

title

Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. (English)

1 reference

14 February 2018

1 reference

4

1 reference

14 February 2018

Julia Calzada-Wack

3

object named as

Julia Calzada-Wack

1 reference

14 February 2018

Roland Kappler

1

0 references

author name string

Regine Bauer

2

1 reference

14 February 2018

Bernhard Hemmerlein

5

1 reference

14 February 2018

Heidi Hahn

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 November 2004

1 reference

14 February 2018

published in

Oncogene

1 reference

14 February 2018

volume

23

1 reference

14 February 2018

issue

54

1 reference

14 February 2018

page(s)

8785-8795

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208133

exact match

0 references

cites work

Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Unbalanced overexpression of the mutant allele in murine Patched mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Immunohistochemistry in the diagnosis of soft tissue tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Cell biology of caveolae and caveolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Expression of caveolin-3 in rat aortic vascular smooth muscle cells is determined by developmental state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Tumor spectrum analysis in p53-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Myf5 and MyoD activation define independent myogenic compartments during embryonic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Molecular characterization of Patched-associated rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Twenty years of p53 research: structural and functional aspects of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Rhabdomyosarcoma--working out the pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Cell division cycle control in embryonal and alveolar rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Mechanisms of p53 loss in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Gli and hedgehog in cancer: tumours, embryos and stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Genome-wide examination of myoblast cell cycle withdrawal during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Rhabdomyosarcoma development in mice lacking Trp53 and Fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

Gene alterations and apoptosis in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

inferred from DOI database lookup

7 January 2021

based on heuristic

Nevoid basal-cell carcinoma syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

inferred from DOI database lookup

7 January 2021

based on heuristic

Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208133

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208133

1 reference

14 February 2018

1 reference

14 February 2018